[Hopespringpcsg] FW: FDA Approves Combination for Metastatic Prostate Cancer

Glen Tolhurst glen46nor at gmail.com
Sat Feb 10 16:00:48 EST 2018


Hi all: 
See 1st article below.
Thx,
Glen

Sent from Mail for Windows 10

From: Cancer Network
Sent: February 9, 2018 11:32 AM
To: glen46nor at gmail.com
Subject: FDA Approves Combination for Metastatic Prostate Cancer

Plus: Could genomic profiling guide treatment in advanced pancreatic cancer?
To view this email as a web page, click here.



HIGHLIGHTS   |  February 9, 2018 
  
FDA Approves Abiraterone/Prednisone for Metastatic Prostate Cancer 
The US Food and Drug Administration has approved abiraterone acetate (Zytiga) tablets in combination with prednisone for the treatment of metastatic prostate cancer patients with high-risk, castration-sensitive disease.

 Read more  



  
COMPASS: Genomic Profiling Could Guide Treatment in Advanced Pancreatic Cancer 
In this interview with Kyaw L. Aung, MBBS, PhD , of the Princess Margaret Cancer Centre, we discuss preliminary results of the COMPASS trial, which used whole-genome sequencing and RNA sequencing to analyze the tumors of patients with advanced pancreatic ductal adenocarcinoma to identify possible first-line treatments.

 Read more  



  
Anti-CD19 CAR T-Cell Therapy Active in Pediatric B-Cell ALL 
A single infusion of the anti-CD19 chimeric antigen receptor T-cell therapy tisagenlecleucel produced durable remission in pediatric and young adult patients with relapsed or refractory B-cell acute lymphoblastic lymphoma.

 Read more  



  
TEST YOUR IMAGE IQ 

  
Patient Presents With Thyroid Mass 
Cesar A. Moran, MD
A 46-year-old man presents with a thyroid mass, and a biopsy is obtained. 


What is the diagnosis?
A. Leiomyoma
B. Adrenal hyperplasia
C. Adrenocortical carcinoma
D. Inflammatory pseudotumor 
 Click here to choose your answer  


  

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.

This email was sent by: UBM Medica, a division of UBM Americas
535 Connecticut Avenue, Suite 300
Norwalk, CT, 06854, USA
NEWSLETTER
Forward to a Friend 
Privacy Statement
Terms of Service
Update Profile
Add/Remove Newsletters
Subscribe to Print
Contact Us 
CONNECT
      


  

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://artsservices.uwaterloo.ca/pipermail/hopespringpcsg/attachments/20180210/d63d2165/attachment-0001.html>


More information about the Hopespringpcsg mailing list